Skip to Content

Prograf

In the US, Prograf (tacrolimus systemic) is a member of the drug class calcineurin inhibitors and is used to treat Organ Transplant - Rejection Prophylaxis and Organ Transplant - Rejection Reversal.

US matches:

UK matches:

Ingredient matches for Prograf

Tacrolimus

Tacrolimus is reported as an ingredient of Prograf in the following countries:

  • Argentina
  • Australia
  • Austria
  • Bosnia & Herzegowina
  • Brazil
  • Canada
  • Chile
  • China
  • Czech Republic
  • Denmark
  • Egypt
  • Georgia
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Israel
  • Italy
  • Latvia
  • Lebanon
  • Malaysia
  • New Zealand
  • Norway
  • Oman
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Tunisia
  • Turkey
  • United Kingdom
  • United States
  • Vietnam

Tacrolimus monohydrate (a derivative of Tacrolimus) is reported as an ingredient of Prograf in the following countries:

  • Austria
  • Bulgaria
  • Croatia (Hrvatska)
  • Finland
  • France
  • Germany
  • Ireland
  • Japan
  • Malta
  • Serbia
  • South Korea
  • Spain
  • Sweden
  • United Kingdom

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide